D. Sulitzeanu

1.5k total citations
106 papers, 1.2k citations indexed

About

D. Sulitzeanu is a scholar working on Radiology, Nuclear Medicine and Imaging, Immunology and Molecular Biology. According to data from OpenAlex, D. Sulitzeanu has authored 106 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 41 papers in Radiology, Nuclear Medicine and Imaging, 31 papers in Immunology and 27 papers in Molecular Biology. Recurrent topics in D. Sulitzeanu's work include Monoclonal and Polyclonal Antibodies Research (33 papers), Brucella: diagnosis, epidemiology, treatment (18 papers) and Bacteriophages and microbial interactions (14 papers). D. Sulitzeanu is often cited by papers focused on Monoclonal and Polyclonal Antibodies Research (33 papers), Brucella: diagnosis, epidemiology, treatment (18 papers) and Bacteriophages and microbial interactions (14 papers). D. Sulitzeanu collaborates with scholars based in Israel, Sweden and United States. D. Sulitzeanu's co-authors include David Naor, Igal Gery, Shih‐Tung Liu, Chi‐Neu Tsai, Chih‐Hung Shu, Yu‐Sun Chang, Chih-Lung Liang, Zvee Gilead, J. W. Lightbown and George Klein and has published in prestigious journals such as Nature, Proceedings of the National Academy of Sciences and The Journal of Immunology.

In The Last Decade

D. Sulitzeanu

99 papers receiving 1.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
D. Sulitzeanu Israel 17 460 375 301 243 191 106 1.2k
Yashar Hirshaut United States 21 322 0.7× 609 1.6× 297 1.0× 139 0.6× 156 0.8× 67 1.2k
Leonhard Korngold United States 21 382 0.8× 160 0.4× 454 1.5× 498 2.0× 87 0.5× 69 1.6k
David J. Flavell United Kingdom 22 564 1.2× 276 0.7× 452 1.5× 206 0.8× 113 0.6× 56 1.3k
Humberto Cosenza United States 23 1.1k 2.4× 239 0.6× 558 1.9× 742 3.1× 181 0.9× 45 1.8k
Philip R. Glade United States 18 486 1.1× 365 1.0× 149 0.5× 67 0.3× 86 0.5× 57 1.1k
Teresa Y. Basham United States 17 1.0k 2.3× 249 0.7× 303 1.0× 387 1.6× 195 1.0× 28 1.6k
M. Hadam Germany 24 1.2k 2.7× 413 1.1× 576 1.9× 226 0.9× 82 0.4× 66 2.0k
N. N. Teng United States 21 497 1.1× 300 0.8× 560 1.9× 384 1.6× 168 0.9× 37 2.1k
Morris O. Dailey United States 25 1.2k 2.6× 320 0.9× 431 1.4× 247 1.0× 94 0.5× 43 1.9k
Viktor A. Bokisch United States 18 1.2k 2.6× 171 0.5× 474 1.6× 469 1.9× 86 0.5× 23 2.1k

Countries citing papers authored by D. Sulitzeanu

Since Specialization
Citations

This map shows the geographic impact of D. Sulitzeanu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by D. Sulitzeanu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites D. Sulitzeanu more than expected).

Fields of papers citing papers by D. Sulitzeanu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by D. Sulitzeanu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by D. Sulitzeanu. The network helps show where D. Sulitzeanu may publish in the future.

Co-authorship network of co-authors of D. Sulitzeanu

This figure shows the co-authorship network connecting the top 25 collaborators of D. Sulitzeanu. A scholar is included among the top collaborators of D. Sulitzeanu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with D. Sulitzeanu. D. Sulitzeanu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Sulitzeanu, D., et al.. (1993). LAK Cells Release a Novel Form of Directly Acting TGFβ, Tightly Bound to a High Molecular Weight Carrier(s). Growth Factors. 8(3). 177–186. 5 indexed citations
2.
Campos‐Lima, Pedro O. de, Sigurbjörg Torsteinsdóttir, Laura Cuomo, et al.. (1993). Antigen processing and presentation by EBV‐carrying cell lines: Cell‐phenotype dependence and influence of the EBV‐encoded LMP1. International Journal of Cancer. 53(5). 856–862. 27 indexed citations
3.
Yarom, Rena, et al.. (1992). Degenerative changes in the A375 melanoma line induced by transforming growth factor beta 1. Immunology Letters. 33(2). 151–156. 3 indexed citations
4.
Klein, George, et al.. (1990). Cross-reactivity between the EBNA-1 p107 peptide, collagen, and keratin: Implications for the pathogenesis of rheumatoid arthritis. Clinical Immunology and Immunopathology. 54(1). 14–25. 39 indexed citations
6.
Weiss, David, et al.. (1989). Culture supernatants of lymphokine-activated killer (LAK) cells contain a high-molecular-weight cytotoxic lymphokine. Immunology Letters. 23(1). 27–30. 7 indexed citations
7.
Sulitzeanu, D. & Mordechai Anafi. (1989). EBV, molecular mimicry and rheumatoid arthritis: a hypothesis. Immunology Letters. 20(2). 89–91. 7 indexed citations
8.
Hatzubai, Ada, Richard A. Lerner, George Klein, & D. Sulitzeanu. (1988). Proteins in normal and malignant cells, cross‐reacting with the latent membrane protein encoded by Epstein‐Barr virus. European Journal of Immunology. 18(8). 1283–1288. 5 indexed citations
9.
Sulitzeanu, D., Robert Szigeti, Ada Hatzubai, et al.. (1988). Antibodies in human sera against the Epstein-Barr virus encoded latent membrane protein (LMP). Immunology Letters. 18(4). 301–306. 4 indexed citations
10.
Sulitzeanu, D.. (1985). Human Cancer-Associated Antigens: Present Status and Implications for Immunodiagnosis. Advances in cancer research. 44. 1–42. 44 indexed citations
11.
Gilead, Zvee, Ada Hatzubai, & D. Sulitzeanu. (1982). Antigens in immune complexes from patients with breast cancer. Cancer Immunology Immunotherapy. 13(3). 153–7. 8 indexed citations
14.
Sulitzeanu, D., et al.. (1971). Cellular Interactions and the Secondary Response in vitro. Nature New Biology. 229(8). 254–255. 42 indexed citations
15.
Sulitzeanu, D.. (1965). Antigenic components of rat connective tissue.. PubMed. 46(5). 481–8. 6 indexed citations
16.
Sulitzeanu, D., et al.. (1965). An Immunogenic Fraction extracted from Brucella abortus Cell Wails by Phenol. Nature. 207(5003). 1308–1309. 1 indexed citations
17.
Sulitzeanu, D., Yasuo Yagi, & David Pressman. (1964). Liver Localizing Antibodies—The Limited Contribution of Ag-Ab Complexes. The Journal of Immunology. 92(5). 724–729. 4 indexed citations
18.
Sulitzeanu, D., Yasuo Yagi, & David Pressman. (1963). Separation of an Antigenic Fraction from Rat Liver Responsible for the Formation of Liver Localizing Antibodies. The Journal of Immunology. 90(3). 424–428. 8 indexed citations
19.
Sulitzeanu, D., et al.. (1960). The Fate of Killed, Radioiodinated Brucella Abortus Injected Into Mice. The Journal of Immunology. 84(6). 551–561. 6 indexed citations
20.
Sulitzeanu, D., et al.. (1960). Observations on Men Vaccinated with a Streptomycin Dependent Brucella Strain. The Journal of Infectious Diseases. 106(1). 77–82. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026